THE ANALYSIS OF QUALITY OF LIFE IN DIABETIC PATIENTS CONSUMING ORAL DIABETIC AGENTS

THE ANALYSIS OF QUALITY OF LIFE IN DIABETIC PATIENTS CONSUMING ORAL DIABETIC AGENTS Dian Asmidawati, Imaniar Noor Faridah, Diah Aryani Perwitasari )Faculty of Pharmacy, Ahmad Dahlan University Correspondence : [email protected] 08975808459 Abstract Background. Diabetes mellitus is one of chronic metabolic disorder characterized by hyperglycemia and abnormalities in carbohydrate, fat, and protein metabolism because of insulin insufficiency. Diabetes mellitus is a chronic disorder which have consequencies in patients’ quality of life. Objective. The research aimed to find out the description about quality of life in diabetic patients and the influence of delivering drug information to the quality of life in diabetic patients who got oral diabetic agents in Puskesmas Umbulharjo 1 Yogyakarta.. Methods. The research was a cohort study at Puskesmas Umbulharjo I. The inclusion criteria were all diabetic patients who got oral diabetic agents and had been receiving the medication for at least one month in Puskesmas Umbulharjo I, patients who are willing to be the respondents, dan the living place of the patients can be reached by the researcher. The exclusion criteria was a patient who had complicated disorder. There were 18 patients in the research who had inclusion criteria. The data being analyzed was a primary data to identify quality of life that was measured using SF-36 questionnaire Indonesian version. Outcome measured. Quality of life domain in diabetic patients Results.The result of the research indicated that 8 domains were a (1) general health perceptions (2) physical health problem (3) physical activities (4) emotional problems, (5) social activities (6) bodily pain (7) vitality and (8) general mental health. The result from eight domains showed that there was no corellation between delivering drug information and quality of life in diabetic patients (p > 0.05). In the other results showed that there was a significant corellation between patient’s adherence and quality of life in diabetic patients in three domains such as general health perceptions, vitality, and general mental health (p < 0.05). Conclusion. In conclusion, the provision of drug information did not affect the quality of life of patients with diabetes mellitus (p > 0.05), whereas the effect of compliance to quality of life resulted that compliance of patients significantly influenced the quality of life of patients with diabetes mellitus in 3 domains, namely physical activities, vitality, and general mental health (p < 0.05). Keywords : Diabetes mellitus, quality of life, delivering drug information , SF-36 questionnar